drugset / Trial / NCT05522998

Efficacy and Safety of Ciprofol in Laparoscopic Sleeve Gastrectomy

NCT05522998

Phase 4 Completed 212 enrolled The Third People's Hospital of Chengdu
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the efficacy and safety of ciprofol for the induction of general anesthesia in obese patients undergoing laparoscopic sleeve gastrectomy. A randomized, parallel, propofol injection positive control study will be conducted to select obese patients who will undergo laparoscopic sleeve gastrectomy in the author's hospital. To evaluate the efficacy and safety, the main observation index, secondary observation indexes, safety evaluation indexes, and the incidence of postoperative adverse reactions will be recorded and compared between the two groups.

Timeline

Start
2023-01-01
Primary completion
2023-06-30
Completion
2024-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Cipepofol Small molecule 0.4 mg/kg Intravenous
Subject Cipepofol Small molecule 0.5 mg/kg Intravenous
Comparator Propofol Small molecule 2 mg/kg Intravenous
Comparator Propofol Small molecule 2.5 mg/kg Intravenous

Indications

No indication recorded.